Elevance Health opens the week with Carelon focus, shares steady

By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-27, 09:07.

Elevance Health (US2855211023) starts the weekend with Carelon in view, and the company trades on the NYSE under the ELV ticker. Nasdaq says Carelon now contributes about 36.3% of operating revenue, giving the segment a clearer weight inside the group model.Nasdaq on Carelon's revenue share

Carelon's revenue weight

Nasdaq also notes that Elevance Health generated a year-to-date share gain of 12.1% at the time of its analysis, while the industry fell 2.9%. The same piece puts the forward price-to-earnings ratio at 13.85, below the industry average of 15.70.

That valuation gap matters because the group pairs insurance with care delivery, pharmacy, and care management through Carelon. The Zacks consensus estimate cited by Nasdaq points to 2026 earnings of 26.92 dollars per share.

Wall Street's current view

MarketBeat shows Elevance Health shares at 394.86 dollars at the close on 2026-06-26, with after-hours trading at 395.55 dollars. That keeps the stock close to the prior session's finish and gives the latest public quote a clear timestamp.MarketBeat quote and session data

For analyst coverage, the Nasdaq article cites the Zacks Rank #2 and the 2026 earnings estimate of 26.92 dollars per share. That combination gives investors a simple read-through on how the market currently prices the business mix.Stockscan consensus snapshot

Carelon's core businesses

Carelon runs pharmacy, care delivery, and care management services inside the broader Elevance Health model. Nasdaq describes it as a growing pillar rather than a side unit, which makes the segment relevant for earnings readers and sector comparables alike.

NYSE price and venue

The Elevance Health shares (US2855211023) trade on 2026-06-26, 07:56 PM Eastern on the NYSE at 395.55 dollars.

Disclaimer: This article is for information only and does not constitute investment advice.